Evidence map›Paper›PMID 29713677›Full record

ArticleEndoscopy international open2018

Narrow band imaging efficiency in evaluation of mucosal healing/relapse of ulcerative colitis.

Seiko Sasanuma, Kazuo Ohtsuka, Shin-Ei Kudo, Noriyuki Ogata, Yasuharu Maeda, Masashi Misawa, Yuichi Mori, Toyoki Kudo, Tomokauzu Hisayuki, Kunihiko Wakamura and 5 more

Registry-linked trialAbstract read
In one paragraph

Article in Endoscopy international open, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06709209 (A Novel Simplified Endoscopic Score aiMed at Evaluating Ulcerative cOlitis Activity Through TXI, RDI and NBI Vascular Assessment and at prEdicting Clinical Outcome and Its Applicability in an arTificial Intelligence System), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06709209 recruitingnot on this mapstarted 2024, after this paper: background citation

A Novel Simplified Endoscopic Score aiMed at Evaluating Ulcerative cOlitis Activity Through TXI, RDI and NBI Vascular Assessment and at prEdicting Clinical Outcome and Its Applicability in an arTificial Intelligence System: the MONET Study

TypeobservationalSponsorUniversity College CorkRan2024 to 2027Enrolled300ConditionsUlcerative Colitis (UC)ArmsColonoscopy after bowel cleansing, Intestinal biopsies, blood sampling, Stool, Clinical follow-up
3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. New Technologies for IBD Endoscopy.Journal of clinical medicine · 2026
    Review
  3. Review
  4. Review
  5. Present and future of endoscopy precision for inflammatory bowel disease.Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society · 2024
    Review
  6. Review
  7. Next-Generation Endoscopy in Inflammatory Bowel Disease.Diagnostics (Basel, Switzerland) · 2023
    Review
  8. New endoscopic tools in inflammatory bowel disease.United European gastroenterology journal · 2022
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Mucosal healing in inflammatory bowel disease: Expanding horizon.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2019
    Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Seiko SasanumaDigestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan.
Kazuo OhtsukaDigestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan.
Shin-Ei KudoDigestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan.
Noriyuki OgataDigestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan.
Yasuharu MaedaDigestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan.
Masashi MisawaDigestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan.
Yuichi MoriDigestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan.
Toyoki KudoDigestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan.
Tomokauzu HisayukiDigestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan.
Kunihiko WakamuraDigestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan.
Takemasa HayashiDigestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan.
Atsushi KatagiriDigestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan.
Hideyuki MiyachiDigestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan.
Toshiyuki BabaDigestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan.
Fumio IshidaDigestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND STUDY

aimsMucosal healing is a current treatment target in ulcerative colitis (UC), while histological remission is another target. The aim of this study was to evaluate the efficiency of magnified narrow band imaging (NBI) findings of mucosal healing and their relationship with histological activity and prognosis. PATIENTS AND

methodsPatients with UC who underwent total colonoscopy between January 2010 and December 2012 with left-sided or total-colitis type UC and achieved clinical remission with an endoscopic Mayo score of 0 or 1 were included. Each colon section was observed with white light and magnified NBI, with the colonoscopy being repeated at 1-year follow-up. We assessed the relationships of magnified NBI with histological disease activity and prognosis. Magnified NBI findings were divided into three categories; honeycomb-like blood vessels (BV-H), blood vessels shaped like bare branches (BV-BB), and blood vessels shaped like vines (BV-V).

resultsFifty-two patients were included. The percentage of remitted mucosa with BV-BB was 37 %, while that of mucosa with scars with BV-H was 35 %. BV-H and BV-BB did not show pathological activity (12/292 and 8/299, respectively), while BV-V showed high pathological activity (27/33, 81 %). There was a correlation between magnified NBI findings and pathological findings (

conclusionMagnified NBI findings showed a good relationship with histological activity. This suggests that we could estimate histological activity without biopsy, and also the possibility of predicting relapse over the following year.

Identifiers

PMID29713677
PMCPMC5906109

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.